NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
---|---|---|---|---|---|
Net Sales | ₹365 Cr | ₹333 Cr | ₹301 Cr | ₹278 Cr | ₹138 Cr |
What is the latest Revenue of NATH BIOGENES (INDIA) ?
Year | Revenue |
---|---|
Mar2025 | ₹365 Cr |
Mar2024 | ₹333 Cr |
Mar2023 | ₹301 Cr |
Mar2022 | ₹278 Cr |
Mar2013 | ₹138 Cr |
How is Revenue of NATH BIOGENES (INDIA) Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹365 Cr | 9.71 | |
Mar2024 | ₹333 Cr | 10.37 | |
Mar2023 | ₹301 Cr | 8.26 | |
Mar2022 | ₹278 Cr | 102.15 | |
Mar2013 | ₹138 Cr | - |
Compare Revenue of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹326.7 Cr | 3.6% | -2.2% | -19.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,108.7 Cr | -4% | 3% | -25.9% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,871.3 Cr | -5.2% | -2% | 9.2% | Stock Analytics | |
VENKYS (INDIA) | ₹2,091.6 Cr | -1.2% | -0.6% | -31.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,406.1 Cr | -1.6% | -6.4% | -28.1% | Stock Analytics | |
INDO US BIOTECH | ₹274.6 Cr | -1.6% | -7.3% | -57.4% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 3.6% |
-2.2% |
-19.7% |
SENSEX | -1.2% |
0.5% |
-1.8% |
You may also like the below Video Courses